|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/53 | |||
| G01N 33/68 | |||
| C07K 14/705 | |||
| G01N 33/72 | |||
| G01N 33/74 |
| (11) | Number of the document | 2912462 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13848471.2 |
| Date of filing the European patent application | 2013-10-23 | |
| (97) | Date of publication of the European application | 2015-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/066350 |
| Date | 2013-10-23 |
| (87) | Number | WO 2014/066486 |
| Date | 2014-05-01 |
| (30) | Number | Date | Country code |
| 201261718126 P | 2012-10-24 | US |
| (72) |
SUNG, Victoria, US
CHOPRA, Rajesh, GB
HERMINE, Olivier, FR
CRUZ MOURA, Ivan, FR
DUSSIOT, Michael, FR
TROVATI MACIEL, Thiago, FR
FRICOT, Aurelie, FR
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | BIOMARKER FOR USE IN TREATING ANEMIA |
| BIOMARKER FOR USE IN TREATING ANEMIA |